Cargando…

Antibody–drug conjugates: Recent advances in linker chemistry

Antibody–drug conjugates (ADCs) are gradually revolutionizing clinical cancer therapy. The antibody–drug conjugate linker molecule determines both the efficacy and the adverse effects, and so has a major influence on the fate of ADCs. An ideal linker should be stable in the circulatory system and re...

Descripción completa

Detalles Bibliográficos
Autores principales:	Su, Zheng, Xiao, Dian, Xie, Fei, Liu, Lianqi, Wang, Yanming, Fan, Shiyong, Zhou, Xinbo, Li, Song
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8727783/ https://www.ncbi.nlm.nih.gov/pubmed/35024314 http://dx.doi.org/10.1016/j.apsb.2021.03.042

Ejemplares similares

Antibody-Drug Conjugate Using Ionized Cys-Linker-MMAE as the Potent Payload Shows Optimal Therapeutic Safety
por: Wang, Yanming, et al.
Publicado: (2020)

Antibody-drug conjugates: recent advances in conjugation and linker chemistries
por: Tsuchikama, Kyoji, et al.
Publicado: (2016)

Synthesis and evaluation of highly releasable and structurally stable antibody-SN-38-conjugates
por: Liu, Lianqi, et al.
Publicado: (2021)

Development of applicable thiol-linked antibody–drug conjugates with improved stability and therapeutic index
por: Wang, Yanming, et al.
Publicado: (2022)

A bifunctional molecule-based strategy for the development of theranostic antibody-drug conjugate
por: Xiao, Dian, et al.
Publicado: (2021)

From prodrug to pro-prodrug: hypoxia-sensitive antibody–drug conjugates
por: Wang, Yanming, et al.
Publicado: (2022)

Research progress on repositioning drugs and specific therapeutic drugs for SARS-CoV-2
por: Fan, Shiyong, et al.
Publicado: (2020)

Novel Silyl Ether-Based Acid-Cleavable Antibody-MMAE Conjugates with Appropriate Stability and Efficacy
por: Wang, Yanming, et al.
Publicado: (2019)

Development and Properties of Valine-Alanine based Antibody-Drug Conjugates with Monomethyl Auristatin E as the Potent Payload
por: Wang, Yanming, et al.
Publicado: (2017)

Improving Antibody‐Tubulysin Conjugates through Linker Chemistry and Site‐Specific Conjugation
por: Hamilton, Joseph Z., et al.
Publicado: (2021)

Sulfatase-cleavable linkers for antibody-drug conjugates
por: Bargh, Jonathan D., et al.
Publicado: (2020)

Peroxide-cleavable linkers for antibody–drug conjugates
por: Ashman, Nicola, et al.
Publicado: (2023)

Linker Design Impacts Antibody-Drug Conjugate Pharmacokinetics and Efficacy via Modulating the Stability and Payload Release Efficiency
por: Su, Dian, et al.
Publicado: (2021)

Linkers: An Assurance for Controlled Delivery of Antibody-Drug Conjugate
por: Sheyi, Rotimi, et al.
Publicado: (2022)

Lysosomal-Cleavable Peptide Linkers in Antibody–Drug Conjugates
por: Balamkundu, Seetharamsing, et al.
Publicado: (2023)

Effects of antibody, drug and linker on the preclinical and clinical toxicities of antibody-drug conjugates
por: Donaghy, Heather
Publicado: (2016)

Linkers Having a Crucial Role in Antibody–Drug Conjugates
por: Lu, Jun, et al.
Publicado: (2016)

Click Chemistry and Multicomponent Reaction for Linker Diversification of Zinc Dipicolylamine-Based Drug Conjugates
por: Tsai, Ching-Hua, et al.
Publicado: (2022)

Antibody–drug conjugates: Recent advances in payloads
por: Wang, Zhijia, et al.
Publicado: (2023)

Impact of linker-drug on ion exchange chromatography separation of antibody-drug conjugates
por: Zhang, Zhaorui, et al.
Publicado: (2019)

Site-specific labeling of an anti-MUC1 antibody: probing the effects of conjugation and linker chemistry on the internalization process
por: Xu, Hongjiao, et al.
Publicado: (2019)

Single Mutation on Trastuzumab Modulates the Stability of Antibody–Drug Conjugates Built Using Acetal-Based Linkers and Thiol-Maleimide Chemistry
por: Ferhati, Xhenti, et al.
Publicado: (2022)

Acid-cleavable thiomaleamic acid linker for homogeneous antibody–drug conjugation
por: Castañeda, Lourdes, et al.
Publicado: (2013)

Recent advances of antibody drug conjugates for clinical applications
por: Zhao, Pengxuan, et al.
Publicado: (2020)

Exatecan Antibody Drug Conjugates Based on a Hydrophilic Polysarcosine Drug-Linker Platform
por: Conilh, Louise, et al.
Publicado: (2021)

Computational Construction of Antibody–Drug Conjugates Using Surface Lysines as the Antibody Conjugation Site and a Non-cleavable Linker
por: Filntisi, Arianna, et al.
Publicado: (2014)

An Efficient Conjugation Approach for Coupling Drugs to Native Antibodies via the Pt(II) Linker Lx for Improved Manufacturability of Antibody–Drug Conjugates
por: Merkul, Eugen, et al.
Publicado: (2021)

Convenient methods for preparing π-conjugated linkers as building blocks for modular chemistry
por: Kulhánek, Jiří, et al.
Publicado: (2009)

On the use of DNA as a linker in antibody-drug conjugates: synthesis, stability and in vitro potency
por: Dovgan, Igor, et al.
Publicado: (2020)

Multivalent peptidic linker enables identification of preferred sites of conjugation for a potent thialanstatin antibody drug conjugate
por: Puthenveetil, Sujiet, et al.
Publicado: (2017)

Incorporation of Hydrophilic Macrocycles Into Drug-Linker Reagents Produces Antibody-Drug Conjugates With Enhanced in vivo Performance
por: Evans, Nick, et al.
Publicado: (2022)

Current ADC Linker Chemistry
por: Jain, Nareshkumar, et al.
Publicado: (2015)

Design and Validation of Linkers for Site-Specific Preparation of Antibody–Drug Conjugates Carrying Multiple Drug Copies Per Cysteine Conjugation Site
por: Kumar, Amit, et al.
Publicado: (2020)

Development of Photoremovable Linkers as a Novel Strategy to Improve the Pharmacokinetics of Drug Conjugates and Their Potential Application in Antibody–Drug Conjugates for Cancer Therapy
por: Johan, Audrey Nathania, et al.
Publicado: (2022)

Glutamic acid–valine–citrulline linkers ensure stability and efficacy of antibody–drug conjugates in mice
por: Anami, Yasuaki, et al.
Publicado: (2018)

Antibody Conjugates-Recent Advances and Future Innovations
por: Leung, Donmienne, et al.
Publicado: (2020)

Antibody-Drug Conjugates for Cancer Therapy: Chemistry to Clinical Implications
por: Dan, Nirnoy, et al.
Publicado: (2018)

Improving the Serum Stability of Site-Specific Antibody Conjugates with Sulfone Linkers
por: Patterson, James T., et al.
Publicado: (2014)

Construction of paclitaxel-based antibody–drug conjugates with a PEGylated linker to achieve superior therapeutic index
por: Shao, Ting, et al.
Publicado: (2020)

A Bispecific METxMET Antibody–Drug Conjugate with Cleavable Linker Is Processed in Recycling and Late Endosomes
por: Perez Bay, Andres E., et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_1nkkjfp37f3cfa2q3qs4sbbhl8